References
- NeogiTClinical practice. GoutN Engl J Med2011364544345221288096
- TerkeltaubREdwardsNLGout: Diagnosis and Management of Gouty Arthritis and Hyperuricemia3rd edWest Islip, NYProfessional Communications, Inc.2013
- KhannaDFitzgeraldJDKhannaPP2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemiaArthritis Care Res (Hoboken)201264101431144623024028
- RichettePDohertyMPascualE2016 updated EULAR evidence-based recommendations for the management of goutAnn Rheum Dis Epub2016725
- ZhangWDohertyMBardinTEULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)Ann Rheum Dis200665101312132416707532
- BobulescuIAMoeOWRenal transport of uric acid: evolving concepts and uncertaintiesAdv Chronic Kidney Dis201219635837123089270
- FleischmannRKerrBYehLTPharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemiaRheumatology (Oxford)201453122167217424509406
- GirardetJ-LMinerJNUrate crystal deposition disease and gout – new therapies for an old problemAnnu Rep Med Chem201449151164
- ZhuYPandyaBJChoiHKComorbidities of gout and hyperuricemia in the US general population: NHANES 2007–2008Am J Med2012125767968722626509
- SaagKGFitz-PatrickDKopickoJLesinurad combined with allopurinol: randomized, double-blind, placebo-controlled study in gout subjects with inadequate response to standard of care allopurinol (a US-based study)Arthritis Rheumatol Epub2016826
- ZURAMPIC® (lesinurad) tablets [prescribing information]Wilmington, DEAstraZeneca Pharmaceuticals LP2016 Available from: http://www.azpicentral.com/zurampic/zurampic.pdfAccessed July 22, 2016
- ZURAMPIC® (lesinurad) tablets [summary of product characteristics]London, UKAstraZeneca UK LTD2016 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003932/WC500203066.pdfAccessed July 22, 2016